Xiaojin Shi is currently the Executive Director and Global Clinical Head for Late Development Oncology in R&D at AstraZeneca. They previously held various roles at AstraZeneca, including Global Clinical Program Lead and Head of Medical and Clinical at BioVentures. From 2002 to 2012, Xiaojin served as the Oncology Medical Director in Japan, contributing significantly to the field during their tenure. Their extensive experience in oncology and clinical research has been a cornerstone of their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices